Approval · Notice of Compliance 3728 · 1997
TIAZAC: Notice of Compliance 3728
Issued April 15, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3728
- Date
- April 15, 1997
- Company
- Biovail Corporation
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antihypertensive
Products in this notice
Medicinal ingredients
- DILTIAZEM HCL 120 MG per CAP
- DILTIAZEM HCL 180 MG per CAP
- DILTIAZEM HCL 240 MG per CAP
- DILTIAZEM HCL 300 MG per CAP
- DILTIAZEM HCL 360 MG per CAP